Caitriona M. O'Driscoll

School of Pharmacy University College Cork, Cork, County Cork, Ireland 
"Caitriona O'Driscoll"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Mendonça MCP, Sun Y, Cronin MF, et al. (2023) Cyclodextrin-Based Nanoparticles for Delivery of Antisense Oligonucleotides Targeting Huntingtin. Pharmaceutics. 15
Knox EG, Aburto MR, Tessier C, et al. (2022) Microbial-derived metabolites induce actin cytoskeletal rearrangement and protect blood-brain barrier function. Iscience. 25: 105648
Knox EG, Lynch CMK, Lee YS, et al. (2022) The gut microbiota is important for the maintenance of blood-cerebrospinal fluid barrier integrity. The European Journal of Neuroscience
Kont A, Mendonça MCP, Cronin MF, et al. (2022) Co-Formulation of Amphiphilic Cationic and Anionic Cyclodextrins Forming Nanoparticles for siRNA Delivery in the Treatment of Acute Myeloid Leukaemia. International Journal of Molecular Sciences. 23
Knox EG, Aburto MR, Clarke G, et al. (2022) The blood-brain barrier in aging and neurodegeneration. Molecular Psychiatry
Sun D, Zou Y, Song L, et al. (2021) A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer. Acta Pharmaceutica Sinica. B. 12: 378-393
Mendonça MCP, Cronin MF, Cryan JF, et al. (2021) Modified cyclodextrin-based nanoparticles mediated delivery of siRNA for huntingtin gene silencing across an in vitro BBB model. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. 169: 309-318
Zou Y, Xiao F, Song L, et al. (2021) A folate-targeted PEGylated cyclodextrin-based nanoformulation achieves co-delivery of docetaxel and siRNA for colorectal cancer. International Journal of Pharmaceutics. 120888
Mendonça MCP, Kont A, Aburto MR, et al. (2021) Advances in the Design of (Nano)Formulations for Delivery of Antisense Oligonucleotides and Small Interfering RNA: Focus on the Central Nervous System. Molecular Pharmaceutics
Presas E, Tovar S, Cuñarro J, et al. (2020) Pre-clinical evaluation of a modified cyclodextrin-based nanoparticle for intestinal delivery of Liraglutide. Journal of Pharmaceutical Sciences
See more...